Concord Biotech Limited

NSEI:CONCORDBIO 株式レポート

時価総額:₹189.9b

Concord Biotech 将来の成長

Future 基準チェック /56

Concord Biotech is forecast to grow earnings and revenue by 25.5% and 19.1% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 24.5% in 3 years.

主要情報

25.5%

収益成長率

25.3%

EPS成長率

Pharmaceuticals 収益成長18.4%
収益成長率19.1%
将来の株主資本利益率24.5%
アナリストカバレッジ

Low

最終更新日17 Oct 2024

今後の成長に関する最新情報

Recent updates

Do Concord Biotech's (NSE:CONCORDBIO) Earnings Warrant Your Attention?

Sep 15
Do Concord Biotech's (NSE:CONCORDBIO) Earnings Warrant Your Attention?

Concord Biotech Limited (NSE:CONCORDBIO) Not Lagging Market On Growth Or Pricing

Jul 23
Concord Biotech Limited (NSE:CONCORDBIO) Not Lagging Market On Growth Or Pricing

Is Concord Biotech (NSE:CONCORDBIO) Using Too Much Debt?

Feb 14
Is Concord Biotech (NSE:CONCORDBIO) Using Too Much Debt?

業績と収益の成長予測

NSEI:CONCORDBIO - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202718,2006,3024,230N/A3
3/31/202615,0904,9383,127N/A4
3/31/202512,3083,7542,440N/A4
6/30/202410,3793,132N/AN/AN/A
3/31/202410,1693,0811,7982,655N/A
12/31/20239,7063,046N/AN/AN/A
9/30/20239,7043,0441,5892,665N/A
6/30/20238,6702,453N/AN/AN/A
3/31/20238,5322,4011,0092,460N/A
3/31/20227,1291,7495262,081N/A
3/31/20216,1692,349-3741,668N/A
3/31/20205,1231,691-61,548N/A

アナリストによる今後の成長予測

収入対貯蓄率: CONCORDBIO's forecast earnings growth (25.5% per year) is above the savings rate (6.7%).

収益対市場: CONCORDBIO's earnings (25.5% per year) are forecast to grow faster than the Indian market (18.1% per year).

高成長収益: CONCORDBIO's earnings are expected to grow significantly over the next 3 years.

収益対市場: CONCORDBIO's revenue (19.1% per year) is forecast to grow faster than the Indian market (10.2% per year).

高い収益成長: CONCORDBIO's revenue (19.1% per year) is forecast to grow slower than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: CONCORDBIO's Return on Equity is forecast to be high in 3 years time (24.5%)


成長企業の発掘